Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

DEFTA Partners

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 32
Average round size
info
The average size of a deal this fund participated in
$12M
Portfolio companies 19
Rounds per year 0.82
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.41
Exits 5
Key employees 3
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Medical
  • Biotechnology
  • Health Care
  • Software
  • Mobile
Summary

In 1984 was created DEFTA Partners, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the San Francisco.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the DEFTA Partners, startups are often financed by Hatteras Venture Partners, 180 Degree Capital, Walden Venture Capital. The meaningful sponsors for the fund in investment in the same round are Walden Venture Capital, LabCorp, Hatteras Venture Partners. In the next rounds fund is usually obtained by Walden Venture Capital, Spectrum Health Ventures, Redpoint.

The overall number of key employees were 3.

Considering the real fund results, this VC is 4 percentage points less often commits exit comparing to other organizations. The higher amount of exits for fund were in 2009. The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2019. This DEFTA Partners works on 3 percentage points less the average amount of lead investments comparing to the other organizations. The fund is generally included in less than 2 deals every year.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline ORIG3N, Intraspect Software, BIoEclipse Therapeutics The fund has no exact preference in some founders of portfolio startups. If startup sums 5+ of the founder, the chance for it to be financed is low. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Video, Blockchain.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of DEFTA Partners:
Typical Co-investors
DEFTA Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after DEFTA Partners:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
62 Capital Australia, Nedlands, Western Australia
D-Ax Corporate Venture Capital Stockholm, Stockholm County, Sweden
GENESIS Ventures -
Hua Ventures China, Fujian, Futian
LF Investment -
Magnetic Fund -
Maven Ventures California, Palo Alto, United States
Michael Grabner Media GmbH Austria, Vienna
Mizrahi Tefahot Bank Israel, Tel Aviv, Tel Aviv District
Ningbo Zeshi Touzi Guanli Co., Ltd China, Ningbo, Zhejiang
Nishikawa Associates Japan, Kanagawa Prefecture, Kawasaki
Protean Energy Advisors, LLC -
RenaissanceRe Holdings Bermuda, Hamilton
Scenic Investments -
Synchrony Bio Missouri, Saint Louis, United States
Tenacious Ventures Australia, Melbourne, Victoria
Tony muscarella -
Ying Fund California, Los Angeles, United States
Zero Point Holding -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Endogena Therapeutics

Biotechnology
Medical
Therapeutics
$21M13 Dec 2021 San Francisco, California, United States

InformAI

Artificial Intelligence
Health Care
Image Recognition
Machine Learning
Medical
Software
$1M01 May 2021 Houston, Texas, United States

Acepodia

Biotechnology
Health Care
Therapeutics
$47M16 Mar 2021 Vallejo, California, United States

Endogena Therapeutics

Biotechnology
Medical
Therapeutics
$8M28 Jan 2021 San Francisco, California, United States

Aegle Therapeutics

Biotechnology
Clinical Trials
Therapeutics
$6M29 Sep 2020 Miami, Florida, United States

InformAI

Artificial Intelligence
Health Care
Image Recognition
Machine Learning
Medical
Software
$1M26 Jun 2020 Houston, Texas, United States

TARA Biosystems

Biotechnology
Medical
$10M23 Jun 2020 New York, New York, United States

1World Online

Analytics
Big Data
Blockchain
Cryptocurrency
Enterprise Software
Market Research
Mobile
Software
$8M21 Feb 2020 Redwood City, California, United States

Aegle Therapeutics

Biotechnology
Clinical Trials
Therapeutics
$4M09 Jan 2020 Miami, Florida, United States
News
Israel’s DiA gets $14M to expand AI-driven ultrasound analysis

– Israel-based AI healthtech company, DiA Imaging Analysis, which is using deep learning and machine learning to automate analysis of ultrasound scans, has closed a $14m Series B round of funding.
– Backers in the growth round, which comes three years after DiA last raised, include new investors Alchimia Ventures, Downing Ventures, ICON Fund, Philips and XTX Ventures — with existing investors also participating, including CE Ventures, Connecticut Innovations, Defta Partners, Mindset Ventures, and Dr Shmuel Cabilly.
– The latest financing will allow DiA to continue expanding its product range and go after new and expanded partnerships with ultrasound vendors, PACS/Healthcare IT companies, resellers and distributors while continuing to build out its presence across three regional markets.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent DEFTA Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 32
Average round size 12M
Rounds per year 0.82
Peak activity year 2018
Lead investments 6
Follow on index 0.41
Exits 5
Group Appearance index 0.94

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Endogena Therapeutics

Biotechnology
Medical
Therapeutics
$21M13 Dec 2021 San Francisco, California, United States

InformAI

Artificial Intelligence
Health Care
Image Recognition
Machine Learning
Medical
Software
$1M01 May 2021 Houston, Texas, United States

Acepodia

Biotechnology
Health Care
Therapeutics
$47M16 Mar 2021 Vallejo, California, United States

Endogena Therapeutics

Biotechnology
Medical
Therapeutics
$8M28 Jan 2021 San Francisco, California, United States

Aegle Therapeutics

Biotechnology
Clinical Trials
Therapeutics
$6M29 Sep 2020 Miami, Florida, United States

InformAI

Artificial Intelligence
Health Care
Image Recognition
Machine Learning
Medical
Software
$1M26 Jun 2020 Houston, Texas, United States

TARA Biosystems

Biotechnology
Medical
$10M23 Jun 2020 New York, New York, United States

1World Online

Analytics
Big Data
Blockchain
Cryptocurrency
Enterprise Software
Market Research
Mobile
Software
$8M21 Feb 2020 Redwood City, California, United States

Aegle Therapeutics

Biotechnology
Clinical Trials
Therapeutics
$4M09 Jan 2020 Miami, Florida, United States
Crunchbase icon

Content report

The following text will be sent to our editors: